Domain Registration

Mexico deaths pass 100,000 as fragments found in Victorian sewage

  • November 21, 2020

The US Food and Drug Administration’s outside advisers will meet on 10 December to discuss whether to authorise the Covid-19 vaccine developed by Pfizer Inc and German partner BioNTech for emergency use, the agency said on Friday.

The move comes after Pfizer applied for the authorisation of its Covid-19 vaccine earlier in the day, the first such application in a major step toward providing protection against the new coronavirus.

“While we cannot predict how long the FDA’s review will take, the FDA will review the request as expeditiously as possible,” FDA commissioner Stephen Hahn said in a statement.

The meeting of Vaccines and Related Biological Products Advisory Committee will discuss the safety and effectiveness of the vaccine candidate.

The FDA is not obligated to abide by its advisory panel recommendations, but typically does.

Related News